Two Sigma Investments
SLNO

Two Sigma Investments’s Soleno Therapeutics SLNO Stock Holding History

Two Sigma Investments’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-48,092
Closed -$1.61M – 5395
2026
Q1 		$1.61M Buy
+48,092
New +$1.89M ﹤0.01% 2925
2022
Q3 		– Sell
-9,970
Closed -$28K – 2791
2022
Q2 		$28K Sell
9,970
-3,933
-28% -$10.9K ﹤0.01% 2383
2022
Q1 		$47K Sell
13,903
-6,733
-33% -$34.9K ﹤0.01% 2494
2021
Q4 		$127K Sell
20,636
-3,754
-15% -$39.4K ﹤0.01% 4019
2021
Q3 		$338K Buy
24,390
+9,840
+68% +$137K ﹤0.01% 3571
2021
Q2 		$249K Sell
14,550
-9,552
-40% -$161K ﹤0.01% 3639
2021
Q1 		$456K Sell
24,102
-9,739
-29% -$314K ﹤0.01% 3008
2020
Q4 		$980K Sell
33,841
-5,666
-14% -$164K ﹤0.01% 2031
2020
Q3 		$1.49M Buy
39,507
+36,282
+1,125% +$1.06M 0.01% 1490
2020
Q2 		$107K Buy
+3,225
New +$140K ﹤0.01% 2780

Two Sigma Investments's SLNO Position: Q2 2026 in Review

Two Sigma Investments sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 48,092 shares — an estimated $1.61M sold.

Two Sigma Investments first reported a position in SLNO in Q2 2020 and held it in 10 quarters. The position peaked at $1.61M in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

  • Two Sigma Investments reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Investments sold 48,092 Soleno Therapeutics shares in Q2 2026, an estimated $1.61M.
  • Two Sigma Investments first reported a position in Soleno Therapeutics in Q2 2020 and held it in 10 quarters.
  • Two Sigma Investments's Soleno Therapeutics position peaked at $1.61M in Q1 2026.
  • 0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.